Skip to search formSkip to main contentSkip to account menu

Ribavirin

Known as: RTCA, Ribovirin, RBV 
A synthetic nucleoside analog of ribofuranose with activity against hepatitis C virus and other RNA viruses. Ribavirin is incorporated into viral RNA… 
National Institutes of Health

Related topics

Related topics

41 relations

Narrower (12)

5'-O-galactopyranosyl ribavirinCopegusICN-1229Rebetol
Adenovirus Infections, HumanDrug AllergyHeart DiseasesHemoglobinopathies

Broader (5)

AntimetabolitesAntiviral AgentsNucleoside AnalogsReverse Transcriptase Inhibitors

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2017
Highly Cited
2017
Effectiveness of Elbasvir and Grazoprevir Combination, With or Without Ribavirin, for Treatment-Experienced Patients With Chronic Hepatitis C Infection.
BACKGROUND & AIMS Patients infected with hepatitis C virus (HCV) genotype 1, 4, or 6, with or without cirrhosis, previously… 
Highly Cited
2010
Highly Cited
2010
A sustained virologic response is durable in patients with chronic hepatitis C treated with peginterferon alfa-2a and ribavirin.
BACKGROUND & AIMS A sustained virologic response (SVR) to therapy for hepatitis C virus (HCV) infection is defined as the… 
Highly Cited
2009
Highly Cited
2009
Alliance partners and firm performance: resource complementarity and status association
Bridging the resource-based view and the institutional perspective, this study explores the performance consequences of firms… 
Highly Cited
2006
Highly Cited
2006
Early identification of HCV genotype 1 patients responding to 24 weeks peginterferon α‐2a (40 kd)/ribavirin therapy
Approximately one third of hepatitis C virus (HCV) genotype 1 patients achieved a sustained virological response (SVR) after 24… 
Highly Cited
2006
Highly Cited
2006
Extended treatment duration for hepatitis C virus type 1: comparing 48 versus 72 weeks of peginterferon-alfa-2a plus ribavirin.
BACKGROUND & AIMS The treatment of patients infected with hepatitis C virus (HCV) type 1 remains a challenge necessitating… 
Review
2003
Review
2003
The Choice of Organizational Governance Form and Performance: Predictions from Transaction Cost, Resource-based, and Real Options Theories
Review
2002
Review
2002
Ribavirin's antiviral mechanism of action: lethal mutagenesis?
Abstract. Ribavirin, an antiviral drug discovered in 1972, is interesting and important for three reasons: (a) it exhibits… 
Review
2002
Review
2002
Structural and biological characterization of pegylated recombinant interferon alpha-2b and its therapeutic implications.
Review
1994
Review
1994
Treatment of chronic viral hepatitis.
Highly Cited
1992
Highly Cited
1992
A pilot study of ribavirin therapy for chronic hepatitis C
Interferon‐α therapy is of proven efficacy in chronic hepatitis C, but it is not universally effective and may be associated with… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)